My lab results and how to fix what's wrong with me...

DieselMan

New member
Hello all. I recently did a simple cycle of 500 test E a week with Adex EOD and the standard nolva/clomid pct. well a month after pct gyno came and I lost all my sex drive. Even cialis doesn't help. It's been about 3 months since this happened and it's still ongoing. What do I need to do in order to fix what's wrong with me?

Testosterone 567
LH 2.2
FSH 1.5
Estradiol 32.4

Thanks so much. I appreciate you guys!
 
Hello all. I recently did a simple cycle of 500 test E a week with Adex EOD and the standard nolva/clomid pct. well a month after pct gyno came and I lost all my sex drive. Even cialis doesn't help. It's been about 3 months since this happened and it's still ongoing. What do I need to do in order to fix what's wrong with me?

Testosterone 567
LH 2.2
FSH 1.5
Estradiol 32.4

Thanks so much. I appreciate you guys!

Those are all good numbers. Must be something else.
 
32.4 estradiol can most dedinately cause gyno and low sex drve. I would recomend stand alone arimidex at .25mg eod for 6 weeks. It will drop your e without crushing it, and raise your testosterone. Ween off at half of that dose for 2 weeks so you dont get any sstrogen rebound.


You have to remember everyones body handles different lvls of estrogen differently. Just because its "in range" , doesnt meen that its normal for YOU
 
Last edited:
32.4 estradiol can most dedinately cause gyno and low sex drve. I would recomend stand alone arimidex at .25mg eod for 6 weeks. It will drop your e without crushing it, and raise your testosterone. Ween off at half of that dose for 2 weeks so you dont get any sstrogen rebound.


You have to remember everyones body handles different lvls of estrogen differently. Just because its "in range" , doesnt meen that its normal for YOU

Thanks... I knew something had to be off. I've never had it this bad. Now I get the importance of blood work. I didn't know Adex can raise my test.
 
Im on .25 ed and im not on cycle. I have no problems. My stuff could be underdosed. But your right...25 twice a week could be a better starting point.
 
I'd verify with a physician that we're talking about actual gyno here. I'd also get prolactin looked into.

My .02c :)
 
I thought prolactin was specific for things like tren and deca. I'm gonna try the Adex. Mine may have been under dosed while on cycle. I'll try Rui
 
I thought prolactin was specific for things like tren and deca. I'm gonna try the Adex. Mine may have been under dosed while on cycle. I'll try Rui

Usually yes, but there are other causes which can crop up. Best to have it checked.

I think you'll find it difficult to crash e2 while the feedback loop is open.. you'd need a fairly high dose. Perhaps start with 2x a week if you're worried, but I think ed-eod would be fine like clman. Everyone's different so make sure you check bloods if you go that route :)
 
Usually yes, but there are other causes which can crop up. Best to have it checked.

I think you'll find it difficult to crash e2 while the feedback loop is open.. you'd need a fairly high dose. Perhaps start with 2x a week if you're worried, but I think ed-eod would be fine like clman. Everyone's different so make sure you check bloods if you go that route :)

Guys have been put on 1mg of adex daily. It raised their TT and slightly lowered E2. The key is that the HPTA feedback loop was fully open at the time. This is called AI-monotherapy.

I agreed with checking Prolactin.

By the way, cialis does nothing to affect libido.
 
Guys have been put on 1mg of adex daily. It raised their TT and slightly lowered E2. The key is that the HPTA feedback loop was fully open at the time. This is called AI-monotherapy.

I agreed with checking Prolactin.

By the way, cialis does nothing to affect libido.

Oh wow, good info Tron. Didn't know you could go that high!
 
As men age, serum testosterone levels decrease, a factor that may contribute to some aspects of age-related physiological deterioration. Although androgen replacement has been shown to have beneficial effects in frankly hypogonadal men, its use in elderly men with borderline hypogonadism is controversial. Furthermore, current testosterone replacement methods have important limitations. We investigated the ability of the orally administered aromatase inhibitor, anastrozole, to increase endogenous testosterone production in 37 elderly men (aged 62-74 yr) with screening serum testosterone levels less than 350 ng/dl. Subjects were randomized in a double-blind fashion to the following 12-wk oral regimens: group 1: anastrozole 1 mg daily (n = 12); group 2: anastrozole 1 mg twice weekly (n = 11); and group 3: placebo daily (n = 14). Hormone levels, quality of life (MOS Short-Form Health Survey), sexual function (International Index of Erectile Function), benign prostate hyperplasia severity (American Urological Association Symptom Index Score), prostate-specific antigen, and measures of safety were compared among groups. Mean +/- SD bioavailable testosterone increased from 99 +/- 31 to 207 +/- 65 ng/dl in group 1 and from 115 +/- 37 to 178 +/- 55 ng/dl in group 2 (P < 0.001 vs. placebo for both groups and P = 0.054 group 1 vs. group 2). Total testosterone levels increased from 343 +/- 61 to 572 +/- 139 ng/dl in group 1 and from 397 +/- 106 to 520 +/- 91 ng/dl in group 2 (P < 0.001 vs. placebo for both groups and P = 0.012 group 1 vs. group 2). Serum estradiol levels decreased from 26 +/- 8 to 17 +/- 6 pg/ml in group 1 and from 27 +/- 8 to 17 +/- 5 pg/ml in group 2 (P < 0.001 vs. placebo for both groups and P = NS group 1 vs. group 2). Serum LH levels increased from 5.1 +/- 4.8 to 7.9 +/- 6.5 U/liter and from 4.1 +/- 1.6 to 7.2 +/- 2.8 U/liter in groups 1 and 2, respectively (P = 0.007 group 1 vs. placebo, P = 0.003 group 2 vs. placebo, and P = NS group 1 vs. group 2). Scores for hematocrit, MOS Short-Form Health Survey, International Index of Erectile Function, and American Urological Association Symptom Index Score did not change. Serum prostate-specific antigen levels increased in group 2 only (1.7 +/- 1.0 to 2.2 +/- 1.5 ng/ml, P = 0.031, compared with placebo). These data demonstrate that aromatase inhibition increases serum bioavailable and total testosterone levels to the youthful normal range in older men with mild hypogonadism. Serum estradiol levels decrease modestly but remain within the normal male range. The physiological consequences of these changes remain to be determined.

Here is a link to the study.

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. - PubMed - NCBI
 
Back
Top